Ocular Oncology

This week in ophthalmology: a new ranibizumab biosimilar approval, smartphone-based artificial intelligence (AI) for ocular surface malignancy detection, an update on corneal allogenic intrastromal ring segments in keratoconus, diabetic eye disease data from ADA 2026 and FDA designations for a potential neurotrophic keratitis therapy. Here are five stories to catch up on this week.

A mobile phone-based artificial intelligence (AI) tool may help identify people with suspicious ocular surface lesions before they reach specialist care, according to findings from a nonrandomized clinical trial published in JAMA Ophthalmology.

ASCO 2026 delivered a wealth of late-breaking data across oncology, including several studies of interest to ophthalmologists. Among them was the phase 2/3 OptimUM-02 trial, which reported promising results for darovasertib plus crizotinib in patients with HLA-A*02:01-negative metastatic uveal melanoma. The findings address a significant unmet need in a disease where treatment options remain limited and outcomes are often poor once metastases develop. Although metastatic uveal melanoma is typically managed by multidisciplinary oncology teams, these findings are relevant to ophthalmologists involved in the diagnosis, long-term follow-up and referral of patients with this rare ocular malignancy.

Artificial intelligence was a major theme throughout the ARVO 2026 Annual Meeting, with growing interest in how AI-driven tools could support earlier diagnosis, improve clinical decision-making and expand access to specialist care. In the session AI Developments in Ocular Oncology and Ophthalmic Pathology, Dr Swathi Kaliki (OEU Institute for Eye Cancer, LV Prasad Eye Institute) explored the evolving role of artificial intelligence and machine learning in retinoblastoma screening and classification.

As 2025 draws to a close, we’re celebrating another remarkable year of growth, collaboration and innovation at touchOPHTHALMOLOGY. From thought-provoking expert interviews and peer-reviewed research, to dynamic conference coverage and an expanding portfolio of medical education, this year has been ...

In this episode of Visionary Voices, we welcome Associate Professor Grace Vincent from CQUniversity’s Appleton Institute. A leading expert on sleep and shift work, Grace explores how disrupted sleep affects physician health in both the short and long term, as well as its impact on safety and performance. We also discuss what this means for patient outcomes and share practical strategies to manage sleep loss.

Physician burnout is at a critical point. In this episode, Nicky speaks with Dr Alfred Atanda about why so many physicians are burning out and what can be done to change the trend. From personal experience to system-wide solutions, Dr Atanda shares valuable insights on improving physician well-being and building a more effective healthcare culture.

Taking place from 7–9 June 2025 in Lisbon, Portugal, the SOE Congress is one of Europe's leading multi-specialty ophthalmology meetings. With a world-class scientific programme, this in-person event offers a rich mix of symposia, live surgery, debates, workshops, mystery cases and updates ...

In this episode, we explore the future of continuing medical education (CME) with the team behind touchIME. Hannah Fisher and Matthew Goodwin share insights into global and US trends, the importance of patient inclusivity and how educational outcomes are evolving to better measure the direct impact of learning on clinical practice and patient care.